| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |